Evidence map›Paper›PMID 28112187›Full record

ArticleScientific reports2017

Understanding the dynamics of Toll-like Receptor 5 response to flagellin and its regulation by estradiol.

Ignacio Caballero, James Boyd, Carmen Almiñana, Javier A Sánchez-López, Shaghayegh Basatvat, Mehrnaz Montazeri, Nasim Maslehat Lay, Sarah Elliott, David G Spiller, Michael R H White and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Characterization ofMicrobiology spectrum · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Article
  9. Review
  10. Airway Administration of Flagellin Regulates the Inflammatory Response toAmerican journal of respiratory cell and molecular biology · 2021
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 3 countries.

Ignacio CaballeroAcademic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, United Kingdom.
James BoydMichael Smith Building, Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
Carmen AlmiñanaAcademic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, United Kingdom.
Javier A Sánchez-LópezAcademic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, United Kingdom.
Shaghayegh BasatvatAcademic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, United Kingdom.
Mehrnaz MontazeriAcademic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, United Kingdom.
Nasim Maslehat LayAcademic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, United Kingdom.
Sarah ElliottAcademic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, United Kingdom.
David G SpillerMichael Smith Building, Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
Michael R H WhiteMichael Smith Building, Faculty of Life Sciences, University of Manchester, Manchester, United Kingdom.
Alireza FazeliAcademic Unit of Reproductive and Developmental Medicine, Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, United Kingdom.
University of Sheffield · GBUniversity of Manchester · GB

Funding

Biotechnology and Biological Sciences Research Council BB/K003097/1Medical Research Council G0500346Medical Research Council MR/K015885/1Medical Research Council MR/M008908/1
6 · The paper itself

Abstract

Toll-like receptors (TLRs) are major players of the innate immune system. Once activated, they trigger a signalling cascade that leads to NF-κB translocation from the cytoplasm to the nucleus. Single cell analysis shows that NF-κB signalling dynamics are a critical determinant of transcriptional regulation. Moreover, the outcome of innate immune response is also affected by the cross-talk between TLRs and estrogen signalling. Here, we characterized the dynamics of TLR5 signalling, responsible for the recognition of flagellated bacteria, and those changes induced by estradiol in its signalling at the single cell level. TLR5 activation in MCF7 cells induced a single and sustained NF-κB translocation into the nucleus that resulted in high NF-κB transcription activity. The overall magnitude of NF-κB transcription activity was not influenced by the duration of the stimulus. No significant changes are observed in the dynamics of NF-κB translocation to the nucleus when MCF7 cells are incubated with estradiol. However, estradiol significantly decreased NF-κB transcriptional activity while increasing TLR5-mediated AP-1 transcription. The effect of estradiol on transcriptional activity was dependent on the estrogen receptor activated. This fine tuning seems to occur mainly in the nucleus at the transcription level rather than affecting the translocation of the NF-κB transcription factor.

Indexed as

EstradiolEstrogensFlagellinGene Expression RegulationHumansMCF-7 CellsNF-kappa BProtein TransportSignal TransductionSingle-Cell AnalysisToll-Like Receptor 5Transcription, GeneticEstradiolEstrogensFlagellinNF-kappa BToll-Like Receptor 5

Identifiers

PMID28112187
PMCPMC5256028
OpenAlexW2580898536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.